118 related articles for article (PubMed ID: 6165192)
1. Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
Morishima T; Hanawa S
Acta Derm Venereol; 1981; 61(2):149-50. PubMed ID: 6165192
[TBL] [Abstract][Full Text] [Related]
2. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
Ito S; Kato T; Fujita K
Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
4. [Excretion of 5-S-cysteinyldopa in the urine of Japanese patients with malignant melanoma--a helpful biochemical marker for assessing the progression of disease].
Hanawa S
Nihon Hifuka Gakkai Zasshi; 1983 Mar; 93(4):433-42. PubMed ID: 6411952
[No Abstract] [Full Text] [Related]
5. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
Morishima T; Saito M; Hanawa S
J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
[No Abstract] [Full Text] [Related]
6. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
7. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
8. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
9. Excretion of 5-s-cysteinyldopa in humans with genetically dark skin.
Agrup G; Hansson C; Juldorf F; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(1):69-70. PubMed ID: 84471
[TBL] [Abstract][Full Text] [Related]
10. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
[TBL] [Abstract][Full Text] [Related]
11. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
[TBL] [Abstract][Full Text] [Related]
12. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
Graef V; Paul E
Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte metabolites in the urine of people of different skin colour.
Wirestrand LE; Hansson C; Rosengren E; Rorsman H
Acta Derm Venereol; 1985; 65(4):345-8. PubMed ID: 2413694
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
[TBL] [Abstract][Full Text] [Related]
15. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
Nixon PF
Aust N Z J Surg; 1978 Feb; 48(1):17-21. PubMed ID: 276342
[TBL] [Abstract][Full Text] [Related]
16. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects.
Agrup G; Falck B; Fyge K; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1975; 55(1):7-9. PubMed ID: 46677
[TBL] [Abstract][Full Text] [Related]
17. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
Tardy J; Barrois JP; Bendelac A; Leonard F; Triller R; Jardillier JC; Kalis B
Photodermatol; 1987 Aug; 4(4):205-8. PubMed ID: 3124084
[TBL] [Abstract][Full Text] [Related]
19. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
20. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.
Kågedal B; Pettersson A
J Chromatogr; 1983 Feb; 272(2):287-97. PubMed ID: 6403561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
